Biopreservation Market to Achieve Significant Growth in the Near Future – The Daily Chronicle

Data Bridge Market Research has recently published the Global research Report Titled Biopreservation Market. The study provides an overview of current statistics and future predictions of the Global Biopreservation Market. The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data.

Asia-Pacific biopreservation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2.57 billion by 2027 growing at a CAGR of 18.78% in the above-mentioned forecast period. The market growth may be attributed to increased health care costs and R&D advances in biobank and regenerative medicine and a growing trend in the conservation of new-born cord blood stem cells.

FREE Sample Copy of Research Report Click Here:

The Global Biopreservation Market research report assembles data collected from different regulatory organizations to assess the growth of the segments. In addition, the study also appraises the global Biopreservation market on the basis of topography. It reviews the macro- and microeconomic features influencing the growth of the Biopreservation Market in each region. Various methodological tools are used to analyze the growth of the worldwide Biopreservation market.

Top Key Vendors Covered in the report:

Thermo Fisher Scientific Inc., Sigma-Aldrich Co., LabVantage Solutions, Inc., Taylor-Wharton, Panasonic Corporation, QIAGEN, VWR International, LLC, Teva Pharmaceutical Industries Ltd, Henan Wobo Oil Machinery Equipment Co. Ltd., Shanghai Xinglu Chemical Technology Co.,Ltd,, among other domestic players.

Regions included:

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

How Does This Market Insights Help?

Key Pointers Covered in the Biopreservation Market Industry Trends and Forecast to 2026

Why choose us:

A complete value chain of the global Biopreservation market is presented in the research report. It is associated with the review of the downstream and upstream components of the Biopreservation Market. The market is bifurcated on the basis of the categories of products and customer application segments. The market analysis demonstrates the expansion of each segment of the global Biopreservation market. The research report assists the user in taking a decisive step that will be a milestone in developing and expanding their businesses in the global Biopreservation market.

Get Table Of Contents of This Premium Research For Free:


Part 01:Executive Summary

Part 02:Scope of the Report

Part 03:Research Methodology

Part 04:Market Landscape

Part 05:Pipeline Analysis

Pipeline Analysis

Part 06:Market Sizing

Market Definition

Market Sizing

Market Size And Forecast

Part 07:Five Forces Analysis

Bargaining Power Of Buyers

Bargaining Power Of Suppliers

Threat Of New Entrants

Threat Of Substitutes

Threat Of Rivalry

Market Condition

Part 08:Market Segmentation



Market Opportunity

Part 09:Customer Landscape

Part 10:Regional Landscape

Part 11:Decision Framework

Part 12:Drivers and Challenges

Market Drivers

Market Challenges

Part 13:Market Trends

Part 14:Vendor Landscape

Part 15:Vendor Analysis

Vendors Covered

Vendor Classification

Market Positioning Of Vendors

Part 16:Appendix

For More Information or Query or Customization Before Buying, Click Here:

Customization of the Report

Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thanks for reading this article you can also get individual chapter wise section or region wise report versions like North America, Europe, MEA, or Asia Pacific.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rates


US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Read the original:

Biopreservation Market to Achieve Significant Growth in the Near Future - The Daily Chronicle

Read more
Stem Cell Therapy Market to Witness Exponential Growth by 2020-2027 | Leading Players Osiris Therapeutics, Medipost Co., Anterogen Co., Pharmicell…

Fort Collins, Colorado The report on the Stem Cell Therapy Market provides an in-depth assessment of the Stem Cell Therapy market including technological advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, product advancements, and other key features. The report covers market size estimation, share, growth rate, global position, and regional analysis of the market. The report also covers forecast estimations for investments in the Stem Cell Therapy industry from 2020 to 2027.

The report is furnished with the latest market dynamics and economic scenario in regards to the COVID-19 pandemic. The pandemic has brought about drastic changes in the economy of the world and has affected several key segments and growth opportunities. The report provides an in-depth impact analysis of the pandemic on the market to better understand the latest changes in the market and gain a futuristic outlook on a post-COVID-19 scenario.

Global Stem Cell TherapyMarketwas valued at 117.66 million in 2019 and is projected to reach USD255.37 million by 2027, growing at a CAGR of 10.97% from 2020 to 2027.

Get a sample of the report @

The report provides an in-depth analysis of the key developments and innovations of the market, such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report provides a comprehensive overview of the regional growth of each market player.

Additionally, the report provides details about the revenue estimation, financial standings, capacity, import/export, supply and demand ratio, production and consumption trends, CAGR, market share, market growth dynamics, and market segmentation analysis.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

Furthermore, the report utilizes advanced analytical tools such as SWOT analysis and Porters Five Forces Analysis to analyze key industry players and their market scope. The report also provides feasibility analysis and investment return analysis. It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.

Request a discount on the report @

The report is designed with an aim to assist the reader in taking beneficial data and making fruitful decisions to accelerate their businesses. The report provides an examination of the economic scenario, along with benefits, limitations, supply, production, demands, and development rate of the market.

1.Stem Cell Therapy Market, By Cell Source:

Adipose Tissue-Derived Mesenchymal Stem Cells Bone Marrow-Derived Mesenchymal Stem Cells Cord Blood/Embryonic Stem Cells Other Cell Sources

2.Stem Cell Therapy Market, By Therapeutic Application:

Musculoskeletal Disorders Wounds and Injuries Cardiovascular Diseases Surgeries Gastrointestinal Diseases Other Applications

3.Stem Cell Therapy Market, By Type:

Allogeneic Stem Cell Therapy Market, By Application Musculoskeletal Disorders Wounds and Injuries Surgeries Acute Graft-Versus-Host Disease (AGVHD) Other Applications Autologous Stem Cell Therapy Market, By Application Cardiovascular Diseases Wounds and Injuries Gastrointestinal Diseases Other Applications

Request customization of the report @

Regional Analysis of the Market:

For a better understanding of the global Stem Cell Therapy market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread acrossNorth America, Europe, Latin America, Asia-Pacific, and Middle East & Africa.Each region is analyzed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market.

Benefits of the Global Stem Cell Therapy Report:

To learn more about the report, visit @

Thank you for reading our report. To learn more about report details or for customization information, please contact us. Our team will ensure that the report is customized according to your requirements.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390


Continue reading here:

Stem Cell Therapy Market to Witness Exponential Growth by 2020-2027 | Leading Players Osiris Therapeutics, Medipost Co., Anterogen Co., Pharmicell...

Read more
Cord Blood Stem Cells Market 2019 Global Analysis, Research, Review, Applications and Forecast to 2025 – Scientect

Up Market Research (UMR), a prominent market research firm in its own industry, has published a detailed report on Global Cord Blood Stem Cells Market. This market research report provides comprehensive and in-depth analysis on the market which can possibly help an enterprise to identify lucrative opportunities and assist them with fabricating creative business strategies. The market report provides information about the current market scenario regarding the global supply and demand, key market trends and opportunities in the market, and challenges and threats faced by the industry players.

The Cord Blood Stem Cells market report talks about the competitive scenario among the industry players and imparts aspiring and emerging industry players with the future market insights in a detailed manner. This market report includes crucial data and figures which are structured out in a concise yet understandable manner. The research report covers the updates on the government regulations and policies which illustrates key opportunities and challenges of the market. Up Market Research (UMR) has been monitoring the market since few years and collaborated with eminent players of the industry to give better insights on the market. It has conducted vigorous research and implied robust methodology to provide accurate predictions about the market.

You can buy the complete report on @

Impacts of Advancements and COVID-19 on the market.

Amidst the COVID-19, few segments of the market have witnessed a disruption due to the gap in supply and demand which has impacted the growth of the Cord Blood Stem Cells market. Along with this, the latest advancements have changed the market dynamics of the market. This research report covers the wide-range analysis of the COVID-19 impact to the industry and gives out insights on the change in the market scenario due to the advancements.

Get A Free Sample Report @

Market Segmentation

Some of the major companies that are covered in the report.

Advanced Cell TechnologyCalifornia Stem CellCytori TherapeuticsMesoblast LimitedOpexa Therapeutics Inc.Athersys Inc.Geron CorporationNeostem Inc.CBR Systems Inc.CordlifeCryo-CellCryo-Save AG (A Group of Esperite)LifecellStemcyteViacordSmart Cells International Ltd.Cryoviva IndiaCordvidaChina Cord Blood Corporation

Note: Additional companies

Based on the type, the market is segmented into

Allogeneic Stem CellAutologous Stem Cell

Based on the application, the market is segregated into

Autoimmune DiseasesImmunodeficienciesMalignanciesCanersSolid TumorsOthers

Based on the geographical location, the market is segregated into

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Up Market Research (UMR) provides yearly updates on the Cord Blood Stem Cells market that assist the clients to stay ahead in the competitive space.

Why one should buy this Cord Blood Stem Cells Report?

The market research report provides all valuable constituents of the market such as revenue growth, product pricing & analysis, growth potential, and guidelines to tackle the challenges in the market. The report covers all the crucial mergers & acquisitions, partnerships, and collaborations that created further created opportunities or in some cases, challenges for the industry players.

This report includes latest product news, advancements, and updates from the prominent player of the industry that has leveraged their position in the market. It also provides business strategies implemented by the key players and yardstick to arrive on informed business decisions. Moreover, it gives insights on the consumer behavior patterns that can help the enterprise to curate the business strategies accordingly.

Up Market Research (UMR) bestows the clients with the specialized customized options related to the regional analysis, company analysis, and product analysis, among others.

Complete Table Content of the Market

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Cord Blood Stem Cells Market Overview

Cord Blood Stem Cells Supply Chain Analysis

Cord Blood Stem Cells Pricing Analysis

Global Cord Blood Stem Cells Market Analysis and Forecast by Type

Global Cord Blood Stem Cells Market Analysis and Forecast by Application

Global Cord Blood Stem Cells Market Analysis and Forecast by Sales Channel

Global Cord Blood Stem Cells Market Analysis and Forecast by Region

North America Cord Blood Stem Cells Market Analysis and Forecast

Latin America Cord Blood Stem Cells Market Analysis and Forecast

Europe Cord Blood Stem Cells Market Analysis and Forecast

Asia Pacific Cord Blood Stem Cells Market Analysis and Forecast

Middle East & Africa Cord Blood Stem Cells Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, please reach out to us @

About the Company

Up Market Research (UMR) is the largest aggregator of the market research report in the industry with more than 800 global clients. The company has extensively invested in the research analysts training and programs to keep the analyst tapped with the best industry standards and provide the clients with the utmost experience. Our dedicated team has been collaborating with the industry experts to give out the precise data and figures related to the industry. It conducts primary research, secondary research, and consumer surveys to provide an in-depth analysis of the market. The market research firm has worked in several business verticals and has been successful to earn high credentials over the time.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Website https://www.upmarketresearch.comAddress 500 East E Street, Ontario, CA 91764, United States.

Read the rest here:

Cord Blood Stem Cells Market 2019 Global Analysis, Research, Review, Applications and Forecast to 2025 - Scientect

Read more
STEM CELL BANKING Market Outlook, Recent Trends and Growth Forecast 2020-2026 – The Research Process

The report on NEUROSCIENCE ANTIBODIES AND ASSAYS market is a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about NEUROSCIENCE ANTIBODIES AND ASSAYS market size. The estimates featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the NEUROSCIENCE ANTIBODIES AND ASSAYS market, including but not limited to: Regional markets, technology, types, and applications.

The report provides insights on the following sections:

Request Sample Copy of this Report @

As moving to the next segment NEUROSCIENCE ANTIBODIES AND ASSAYS Market report also evaluates the key opportunities in the market and outlines the factors that are and will be driving the growth of the NEUROSCIENCE ANTIBODIES AND ASSAYS industry. The major vendors in the NEUROSCIENCE ANTIBODIES AND ASSAYS market aggressively focused on enhancing their contributions to meet the business goal.

Request Sample Copy of this Report @

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Some of the Highlights about Table of Content of NEUROSCIENCE ANTIBODIES AND ASSAYS Market


2 Executive Summary

3 Market Drivers, Challenges and Trends

4 Marketing, Distributors and Customer

5 Key Players Analysis

Request Customization on This Report @


STEM CELL BANKING Market Outlook, Recent Trends and Growth Forecast 2020-2026 - The Research Process

Read more
Full House and Senate should reauthorize the C.W. Bill Young Cell Transplantation Program | TheHill – The Hill

It is September of a presidential election year, with a divided government and a deeply polarized electorate. Many congressional watchers would tell you that absolutely nothing could pass in this environment. Earlier this month, however, in defiance of the naysayers and in the spirit of all too rare bipartisanship, the House Energy and Commerce Committee overwhelmingly voted to reauthorize the C.W. Bill Young Cell Transplantation Program (the Program).

We must extend this demonstration of bipartisanship and willingness to work together to save American lives to the full House and the Senate and ensure that the Program is reauthorized before it expires at the end of September.

For 30 years, Congress has authorized and re-authorized the Program, which provides access to life-saving bone marrow, peripheral blood stem cell and cord blood transplants for patients living with one of the more than 70 blood cancers or blood disorders for which transplant is the only curative option.

The Program was first established through a partnership with the Navy in 1986, transferred to the NIH for oversight the following year, then authorized by Congress in 1994 and has been reauthorized in 1998, 2005, 2010, and 2015.

During those 30 years, the National Marrow Donor Program/Be The Match (NMDP) has facilitated more than 100,000 lifesaving and life-extending transplants.

While the Program enjoys broad bipartisan and bicameral support, as it has during every other reauthorization, it is still in jeopardy which is why we strongly urge Congress to act swiftly to protect the Program and the patients who rely on it.

Because of its unassailable mission, because of its great successes over three decades, and because the Program is relied upon by more patients than ever before, reauthorization of the national registry remains non-controversial.

Reauthorization was critical before the pandemic, but now because of the wild unpredictability of COVID-19, and its downstream impacts that create life-threatening risk to bone marrow transplant patients, it is even more urgent that Congress reauthorize the Program before adjourning for the election.

Thanks in large part to the national program status afforded to NMDP under the authorizing statue, we were:

These critical victories during the pandemic share two common, and extraordinarily important, threads. First, we would not have been able to secure these victories without NMDPs national program status. And, second, patients in the U.S. would have died had these things not happened.

While we have no way to predict exactly what the next emergencies will look like, we nevertheless know with certainty that they will happen. Based upon the unfathomable experience of the last six months, we know that the lynch pin to the solution will be our national program status.

This is exactly why reauthorization now is so critical.

No lapse in the Program means no lapse in our national program status. And that means no lapse in our ability to move mountains in our efforts to leave no patient without the transplant that they so desperately need.

The members of the House Energy & Commerce Committee proved that even in these most trying political times, Congress can come together and work across the aisle to save the lives of Americans in need. We hope the full House and the Senate will follow suit and act quickly to reauthorize the Program.

Brian Lindberg is the chief legal officer and chief policy officer for the National Marrow Donor Program/Be The Match.

Here is the original post:

Full House and Senate should reauthorize the C.W. Bill Young Cell Transplantation Program | TheHill - The Hill

Read more
Hematopoietic Stem Cells Transplantation Market to Witness a Substantiation between 2017 and 2025 – Scientect

Hematopoietic stem cells are young or immature blood cells found to be living in bone marrow. These blood cells on mature in bone marrow and only a small number of these cells get to enter blood stream. These cells that enter blood stream are called as peripheral blood stems cells. Hematopoietic stem cells transplantation is replacement of absent, diseased or damaged hematopoietic stem cells due to chemotherapy or radiation, with healthy hematopoietic stem cells. Over last 30 years hematopoietic stem cells transplantation market seen rapid expansion and constant expansion with lifesaving technological advances. Hematopoietic stem cells transplantation is also known blood and marrow transplantation which brings about reestablishment of the patients immune and medullary function while treating varied range of about 70 hematological and non-hematological disorders. In general hematopoietic stem cells transplantation is used in treatment of hereditary, oncological, immunological and malignant and non-malignant hematological diseases.

There are two types of peripheral blood stem cell transplants mainly autologous and allogeneic transplantation. In autologous transplants patients own hematopoietic stem cells are harvested or removed before the high-dose treatment that might destroy the patients hematopoietic stem cells. While in allogeneic transplants stem cells are obtained from a tissue type of matched or mismatched donor. Hematopoietic stem cells are harvested from blood or bone marrow and is then frozen to use later. Depending upon the source of hematopoietic stem cells, worldwide there are three types of hematopoietic stem cells transplants namely bone marrow transplant (BMT), peripheral blood stem cell transplant and cord blood transplant. Major drivers in the hematopoietic stem cells transplantation market are establishment of strong and well developed network of hematopoietic stem cells transplantation organizations having global reach and presence has recognized NGO named Worldwide Network for Blood and Marrow Transplantation Group (WBMT) in official relation with World Health Organization (WHO) and rapid increase in number of transplants. Major restraints in hematopoietic stem cells transplantation market is high cost of transplantation and lack of funding for WBMT and other organizations such as regional, national and donor.

To remain ahead of your competitors, request for a sample[emailprotected]

The global market for Hematopoietic stem cells transplantation market is segmented on basis of transplant type, application, disease indication, end user and geography:

To receive extensive list of important regions, Request Methodology here @

Based on transplantation type, hematopoietic stem cells transplantation market is segmented into allogeneic and autologous. Hematopoietic stem cells transplantation market is also segmented by application type into bone marrow transplant (BMT), peripheral blood stem cell transplant and cord blood transplant. The market for hematopoietic stem cells transplantation is majorly driven by bone marrow transplant (BMT) segment. Based on end user hematopoietic stem cells transplantation market is segmented into hospitals and specialty centers. Peripheral blood stem cell transplant type holds the largest market for hematopoietic stem cells transplantation. Hematopoietic stem cells transplantation market is further segmented by disease indication into three main categories i.e. lymphoproliferative disorders, leukemia, and non-malignant disorders. Segment lymphoproliferative disorder holds largest share amongst the three in Hematopoietic stem cells transplantation market. On the basis of regional presence, global hematopoietic stem cells transplantation market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Europe leads the global hematopoietic stem cells transplantation market followed by U.S. due to easy technological applications, funding and high income populations. Other reasons for rise in hematopoietic stem cells transplantation market is high prevalence of lymphoproliferative disorders and leukemia; demand for better treatment options; and easy accessibility and acceptance of population to new technological advances. Transplantation rates in high income countries are increasing at a greater extent but continued rise is also seen in low income countries and expected to rise more. Hematopoietic stem cells transplantation market will have its potential in near future as being a perfect alternative to traditional system in many congenital and acquired hematopoietic disorders management. While India, China and Japan will be emerging as potential markets. An excellent and long term alternative to relief by side effects of chemotherapy, radiotherapy and immune-sensitive malignancies is another driver for hematopoietic stem cells transplantation market. The key players in global hematopoietic stem cells transplantation market are Lonza, Escape Therapeutics, Cesca Therapeutics Inc., Regen BioPharma, Inc., Invitrx Inc, StemGenex, Lion Biotechnologies, Inc., CellGenix GmbH, Actinium Pharmaceuticals, Inc., Pluristem, Kite Pharma, Novartis AG.You Can Request for TOC Here @

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website

See the original post:

Hematopoietic Stem Cells Transplantation Market to Witness a Substantiation between 2017 and 2025 - Scientect

Read more
FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C) – BioSpace

NEW YORK, Sept. 16, 2020 /PRNewswire/ --The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with Multisystem Inflammatory Syndrome in Children (MIS-C). The trial is being led by Dr. Joanne Kurtzberg at Duke University to determine if infusions of hCT-MSCs are safe and can suppress the hyper-inflammatory response and positively impact the symptom course and duration, as well as the long-term effects of this life-threatening syndrome. The hCT-MSCs are manufactured in the Robertson GMP Cell Manufacturing Laboratory at Duke. The U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) Application, and Dr. Kurtzberg will proceed with a multi-site pilot study later this month.

As the school year is underway more children are being diagnosed with the SARS-CoV-2 virus. According to the American Academy of Pediatrics (AAP), the cumulative number of coronavirus cases diagnosed in children has more than tripled between July 2 and September 3 from 165,845 to 513,415. As of September 3rd, children represent at least 9.8% of diagnosed cases in the U.S. and in states such as Alaska, Minnesota, Tennessee, South Carolina, New Mexico and Wyoming, children account for more than 15 percent of total cases. Some of these children have developed very serious disease. The Centers for Disease Control and Prevention reported that as of September 3rd at least 792 children in 42 states have been diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C) and 16 have died.

The Principal Investigator of the study, Joanne Kurtzberg, MD, is the Jerome Harris Distinguished Professor of Pediatrics; Professor of Pathology; Director, Marcus Center for Cellular Cures; Director, Pediatric Blood and Marrow Transplant Program; Director, Carolinas Cord Blood Bank; Co-Director, Stem Cell Transplant Laboratory at Duke University School of Medicine/Duke Health and a leader in transplantation, cell therapy, and regenerative medicine in children. Clinical sites include Duke University (Durham, NC), Children's Healthcare of Atlanta (Atlanta, GA), New York Medical College (Valhalla, NY), and others as cases occur.

"We hope this is just the beginning of our ability to support the development of cell therapies to treat COVID-19 Related Multisystem Inflammatory Syndrome in Children," said Dr. Robin Smith,president of the Cura Foundation. "As students across the country return to in-class instruction, it is more important now than ever to ensure we are equipped with potential treatment options to care for children who develop this serious disease."

About the Sponsors

The Cura Foundationleads a global health movement with the goal to improve human health. Cura unites public and private sectors, partnering with doctors, patients, business leaders, philanthropists and thought leaders to create a collaborative network that tackles major health issues and accelerates funding to advance innovations in medicine. Cura believes that by encouraging interdisciplinary approaches to medicine, promoting preventative measures and advancing the development of breakthrough medical technologies you can improve access to care, streamline health care delivery and eliminate social disparities in health care. The Cura Foundation is a nonsectarian, nonpartisan, public and tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. For more information, please visit:

The Marcus Foundationwas founded in 1989 by Bernie Marcus, co-founder and former CEO of The Home Depot, to support programs in Children and Youth Development, Community, Free Enterprise, National Security, Veterans, Jewish Causes, Healthcare and Medical Research.

Sanford Health, one of the largest health systems in the United States, is dedicated to the integrated delivery of health care, genomic medicine, senior care and services, global clinics, research and affordable insurance. Headquartered in Sioux Falls, South Dakota, the organization includes 46 hospitals, 1,400 physicians and more than 200 Good Samaritan Society senior care locations in 26 states and 10 countries. Learn more about Sanford Health's transformative work to improve the human condition at sanfordhealth.orgor Sanford Health News.

Duke Healthconceptually integrates the Duke University School of Medicine, Duke-NUS Medical School, Duke University School of Nursing, Duke University Health System, Private Diagnostic Clinic (Duke physicians practice), and incorporates the health and health research programs within the Duke Global Health Institute as well as those in schools and centers across Duke University, including the Duke-Robert J. Margolis Center for Health Policy.

Duke Health is committed to conducting innovative basic and clinical research, rapidly translating breakthrough discoveries to patient care and population health, providing a unique educational experience to future clinical and scientific leaders, improving the health of populations, and actively seeking policy and intervention-based solutions to complex global health challenges. Underlying these ambitions is a belief that Duke Health is a destination for outstanding people and a dedication to continually explore new ways to help our people grow, collaborate and succeed.

Alliance for Cell Therapy Now(ACT Now) is an independent, non-profit organization devoted to advancing the availability of and access to safe and effective cell therapies for patients in need. ACT Now convenes experts and stakeholders to develop and advance sound policies that will improve the development, manufacturing, delivery, and improvement of regenerative cell therapies. See


The Cura FoundationRobin Smith, MD,

View original content:

SOURCE Alliance for Cell Therapy Now

Visit link:

FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C) - BioSpace

Read more
Boy, 4, who defied the odds to twice beat leukaemia enjoys first day of school – The Sun

A BOY of four who defied the odds to twice beat leukaemia enjoyed his first day of school.

Josh Stockhills parents admitted they had sometimes feared they would never see him in a uniform.



Josh was eight months old when he was first diagnosed with acute lymphoblastic leukaemia.

He underwent chemotherapy but after a month developed sepsis, and ended up in intensive care.

Mum Kirsty Knighton, 36, said: We were told there was a 50/50 chance he would make it through the night.

Josh endured nine months of chemo, but Kirsty and partner Craig Stockhill, 40, were dealt another devastating blow.

Josh relapsed at two years old and required a bone marrow transplant to survive.

Fortunately, Addenbrookes Hospital in Cambridge found a match in Spain.

Josh who has three older brothers and one younger has recovered well. November marks two years since the op.

And yesterday, proudly clutching his book bag, he arrived smiling at Leighton Primary in Peterborough, Cambs.

Ikea worker Kirsty, from Orton Malborne in Peterborough, said: I got so emotional when he tried the uniform on.

We mark every milestone, and with each one hes getting better and better.

CLUCKED OFFMcDonalds worker says you shouldnt order McChicken at 4am in night shift rant

FOLLOW THE RULESBoris hints at second lockdown if Brits fail to follow 'rule of six'

UNMASKEDTeen who bragged he was 'HMP's finest' after slashing man's throat named by judge

JAWS BREAKER'Record breaking' 11ft killer shark caught in British waters

BABY 'MURDER'Girl dies of 'catastrophic' injuries suffered at 2 days old as parents held


HIGH ALERTNorth East plunged into lockdown from FRIDAY with '10pm pub curfew'

We dont know what the future holds for him. But hes such a jolly child. Hes so excited to start school.

Kirsty spoke out during Childhood Cancer Awareness Month, to urge people to consider donating blood when they can, especially cord blood.

Taken from a babys umbilical cord and placenta after birth, it is rich in stem cells and was crucial in helping save Josh.



GOT a story? RING The Sun on 0207 782 4104 or WHATSAPP on 07423720250 or

Continued here:

Boy, 4, who defied the odds to twice beat leukaemia enjoys first day of school - The Sun

Read more
Lotus childbirth: All you need to know about the new birthing trend – Times of India

When it comes to childbirth, you must have heard of cesarean section, natural childbirth and water birth. But have you ever heard about lotus childbirth? Traces of lotus childbirth are found in historical times and are still prevalent in some areas of the world. Read to know what exactly is lotus childbirth, along with its pros and cons. What exactly is lotus childbirth? Lotus childbirth is basically leaving the umbilical cord attached to the baby. This keeps the baby tied to the placenta, until it falls off itself. The placenta is attached to the baby and the remaining portion of umbilical cord is tied in a knot. The detachment process can take anywhere between 3-8 days. This process is different from the common practice of childbirth, in which the umbilical cord is cut the moment the child is born.Pros of Lotus birthBlood circulationIt is said that keeping the umbilical attached to the baby for a few days post birth boosts his blood circulation. It is a more natural way of getting rid of the cord as well. Rise in hemoglobin levelsAll the red blood cells, iron and nutrients present in the placenta get transferred to the baby during lotus childbirth. Delayed cord clamping can help the babys body absorb the stem cells present inside the umbilical cord. Reduction of psychological shock to the babyChildbirth exposes the baby to the outside world. Keeping the cord attached to the baby makes him feel familiar even after coming out of the womb. It is believed that this process avoids trauma and shock. Cons of Lotus birthRisk of infections Umbilical cord basically becomes a dead organ after birth which starts rotting. It can not only be smelly but also increases the risk of infections. Proper cleaning from time to timeA newborns immune system is highly sensitive and a dead organ might become septic in no time. This is why proper sanitization is required multiple times a day to ensure that the placenta remains hygienic. Make sure you seek your gynacologists advice before opting for this method. Weigh the pros and cons, after which you can choose to adopt the method only under the guidance of a doctor.

See the rest here:

Lotus childbirth: All you need to know about the new birthing trend - Times of India

Read more
Cord Blood Banking Top Companies Growth With Top Players| Recovey From Covid 19 – TC BizNews

Cord Blood Banking Industry 2020 Global Market research report studies the latest Cord Blood Banking industry aspects market size, share, trends, Opportunities and Strategies To Boost Growth, business overview, revenue, demand, marketplace expanding, technological innovations, recent development, and Cord Blood Banking industry scenario during the forecast period (2020-2025).

Download Premium Sample of the Report:

Cord Blood Banking Market is valued at USD 1.24 Billion in 2018 and expected to reach USD 2.83 Billion by 2025 with the CAGR of 12.5 % over the forecast period.

A cord blood bank is a facility that stores umbilical cord blood for future use. Both private and public cord blood banks are developed in response to the reliable for cord blood in treating diseases of the blood and immune systems. Private or family cord blood banks are developed for autologous use or directed donation for a family member. Physicians recommend blood bank facility for a variety of reasons. Nowadays, Umbilical cord blood is used to treat many life-threatening diseases including leukemia, certain other cancers, and blood, immune and metabolic disorders. Over 30,000 transplants worldwide have been performed using stem cells from umbilical cord blood and because stem cell technologies continue to advance, the opportunities to utilize preserved cord blood and are steadily increasing. For example, Cryo-Cells umbilical cord blood banking service processes and cryogenically preserves these cells for potential therapeutic use.

Global cord blood banking market report is segmented on the basis of bank type, and regional & country level. Based upon bank type, cord blood banking market is classified as private, public, and hybrid. The regions covered in this Global Cord blood banking market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Cord blood banking market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Cord blood banking Market Report

Global Cord Blood Banking Market Report covers prominent players are like Singapore Cord Blood Bank, CBR Systems, ViaCord LLC, Cordlife, FamiCord, Cryo-Save, Americord, Global Cord Blood Corporation, LifeCell and Jeevan Stem Cell Foundation and others.

Increasing Demand for Umbilical Cord Blood (UCB) Units for Regenerative Medicine Purposes is one of the Major Factors Drive the Market growth.

Increasing demand for umbilical cord blood (UCB) units for regenerative medicine purposes is expected to drive the growth of cord blood banking market. An increase in the number of UCB transplants specifies an expansion of utility in a broad spectrum of disease conditions. For example, the loaded umbilical cord blood in the stem cell can treat cancer, blood diseases like anemia, and some immune system disorders, which disrupt bodys ability to defend it. Apart from that, additional potential applications of UCB include hematopoietic transplantation, immunotherapy, and tissue engineering and regenerative medicine. In addition, increasing prevalence and incidence rate of chronic diseases is also supplementing the market growth. For example, According to the World Health Organization, chronic disease prevalence is expected to rise by 57% by the year 2020. The increasing number of cancer patients is a major driver for the growth of stem cell/cord blood banking market. In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States. However, stringent regulatory requirements may hamper the market growth. In spite of that, increasing technological developments in the field of cord blood storage and processing are also expected to provide an opportunity for the further growth of the market.

North America is Expected to Dominating the Global Cord Blood Banking Market.

North America market is anticipated to grow at a significant rate in the global cord blood banking market in upcoming years, mainly due to the growing demand for the umbilical cord blood in stem cell analysis in this region. In addition, well developed healthcare infrastructure and high adoption of advanced technology in healthcare in this region are also supplementing the market growth. The umbilical cord blood banking may be public and private. In North America, An estimated 4.0 million umbilical cord blood units have been saved for private or family use. In 2017, there are 28 public cord blood banks in North America. These banks have sufficient capacity for those demanding a donation of cord blood. The European cord blood banking market is a second largest market followed by Asia pacific.

By Bank Type:

By Regional & Country Analysis:

Request Customization of the Report:

1 Market Overview1.1 Product Definition and Market Characteristics1.2 Global Cord Blood Banking Market Size1.3 Market Segmentation1.4 Global Macroeconomic Analysis1.5 SWOT Analysis

3 Associated Industry Assessment3.1 Supply Chain Analysis3.2 Industry Active Participants3.2.1 Suppliers of Raw Materials3.2.2 Key Distributors/Retailers3.3 Alternative Analysis3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape4.1 Industry Leading Players4.2 Industry News4.2.1 Key Product Launch News4.2.2 Expansion Plans

5 Analysis of Leading Companies5.1 Company 15.1.1 Company 1 Company Profile5.1.2 Company 1 Business Overview5.1.3 Company 1 Cord Blood Banking Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.1.4 Company 1 Cord Blood Banking Products Introduction

5.2 Company 25.2.1 Company 2 Company Profile5.2.2 Company 2 Business Overview5.2.3 Company 2 Cord Blood Banking Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.2.4 Company 2 Cord Blood Banking Products Introduction

5.3 Company 35.3.1 Company 3 Company Profile5.3.2 Company 3 Business Overview5.3.3 Company 3 Cord Blood Banking Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.3.4 Company 3 Cord Blood Banking Products Introduction

5.4 Company 45.4.1 Company 4 Company Profile5.4.2 Company 4 Business Overview5.4.3 Company 4 Cord Blood Banking Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.4.4 Company 4 Cord Blood Banking Products Introduction

6 Market Analysis and Forecast, By Product Types6.1 Global Cord Blood Banking Sales, Revenue and Market Share by Types (2015-2020)6.2 Global Cord Blood Banking Market Forecast by Types (2020-2026)6.3 Global Cord Blood Banking Sales, Price and Growth Rate by Types (2015-2020)6.4 Global Cord Blood Banking Market Revenue and Sales Forecast, by Types (2020-2026)

7 Market Analysis and Forecast, By Applications7.1 Global Cord Blood Banking Sales, Revenue and Market Share by Applications (2015-2020)7.2 Global Cord Blood Banking Market Forecast by Applications (2020-2026)7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)7.4 Global Cord Blood Banking Market Revenue and Sales Forecast, by Applications (2020-2026)

8 Market Analysis and Forecast, By Regions8.1 Global Cord Blood Banking Sales by Regions (2015-2020)8.2 Global Cord Blood Banking Market Revenue by Regions (2015-2020)8.3 Global Cord Blood Banking Market Forecast by Regions (2020-2026)Continued.

Read More:

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us







Top Trending Reports:

See more here:

Cord Blood Banking Top Companies Growth With Top Players| Recovey From Covid 19 - TC BizNews

Read more